Maat Pharma
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.
Total raised
€25M
€25,350,000
Funding rounds
2
Investors
1
distinct backers
Active since
2020-05
latest 2020-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood15
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 12y since founding
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-12-02 | Series B | €7.3M | PSIM Fund | View deal → |
| 2020-05-02 | Series B | €18M | — | View deal → |
Investors
1Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software